Pricing Log in Create free account

Immatics N.V. (IMTX) vs Savara Inc. (SVRA)

Immatics N.V. and Savara Inc. are both Biotechnology companies. Immatics N.V. and Savara Inc. are of similar size ($1.1B and $973.9M). Savara Inc. has the higher net margin (0.00% vs −489.4%) and the lower return on invested capital (−12,213.2% vs −84.8%). Across the 14 metrics below, Savara Inc. leads on 8 and Immatics N.V. on 6.

Valuation

Metric IMTX SVRA Biotechnology median
P/E n/m n/m 8.50
P/S 18.67 n/m 9.71
P/B 1.98 7.85 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 13.18 n/m 9.21
Earnings yield (27.68%) (13.03%) (33.15%)
Free cash flow yield (26.17%) (9.81%) (25.50%)

Profitability

Metric IMTX SVRA Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (536.26%) 0.00% 0.00%
Net margin (489.35%) 0.00% 0.00%
Free cash flow margin (488.01%) 0.00% 0.00%
Return on equity (48.53%) (105.48%) (56.36%)
Return on assets (39.83%) (78.28%) (48.04%)
Return on invested capital (84.83%) (12,213.18%) 0.00%

Growth

Metric IMTX SVRA Biotechnology median
Revenue growth (TTM) (64.99%) — 6.02%
EPS growth (last fiscal year) (1,313.33%) (10.42%) 30.26%
Revenue growth, 5-year CAGR 11.81% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IMTX SVRA Biotechnology median
Debt to equity 0.00 0.21 0.00
Current ratio 7.54 10.13 4.72
Net debt to EBITDA 2.04 1.64 0.96

Dividend

Metric IMTX SVRA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric IMTX SVRA Biotechnology median
Market cap 1.07b 973.88m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack